يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Norhammar, A"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Norhammar, Anna Bodegard, Johan Vanderheyden, Marc Tangri, Navdeep Karasik, Avraham Maggioni, Aldo Pietro Sveen, Kari Anne Taveira-Gomes, Tiago Botana, Manuel Hunziker, Lukas Thuresson, Marcus Banerjee, Amitava Sundström, Johan Bollmann, Andreas . Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023, 1-9
    Heart
    heartjnl-2022

  2. 2
    دورية أكاديمية

    المصدر: Norhammar, Anna Bodegard, Johan Eriksson, Jan W. Haller, Hermann Linssen, Gerard C. M. Banerjee, Amitava Karasik, Avraham Mamouris, Pavlos Tangri, Navdeep Taveira-Gomes, Tiago Maggioni, Aldo P. Botana, Manuel Thuresson, Marcus Okami, Suguru Yajima, Toshitaka Kadowaki, Takashi Birkeland, Kåre Inge . Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries. Diabetes, obesity and metabolism. 2022, 24(7), 1277-1287
    Diabetes, obesity and metabolism

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Birkeland, Kåre I. Bodegard, Johan Eriksson, Jan W. Norhammar, Anna Haller, Hermann Linssen, Gerard C.M. Banerjee, Amitava Thuresson, Marcus Okami, Suguru Garal-Pantaler, Elena Overbeek, Jetty Mamza, Jil Billy Zhang, Ruiqi Yajima, Toshitaka Komuro, Issei Kadowaki, Takashi . Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes, obesity and metabolism. 2020, 22(9), 1607-1618
    Diabetes, obesity and metabolism

  5. 5
    دورية أكاديمية

    المصدر: Birkeland, Kåre I. Bodegard, Johan Norhammar, Anna Kuiper, Josephina G. Georgiado, Elena Beekman-Hendriks, Wendy L. Thuresson, Marcus Pignot, Marc Herings, Ron M.C. Kooy, Adriaan . How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes, obesity and metabolism. 2019, 21, 968-974
    Diabetes, obesity and metabolism

  6. 6
    دورية أكاديمية

    المصدر: Cavender, Matthew A. Norhammar, Anna Birkeland, Kåre I. Jørgensen, Marit Eika Wilding, John P. Khunti, Kamlesh Fu, Alex Z. Bodegard, Johan Blak, Betina T. Wittbrodt, Eric Thuresson, Marcus Fenici, Peter Hammar, Niklas Kosiborod, Mikhail . SGLT-2 inhibitors and cardiovascular risk: an analysis of CVD-REAL. Jo
    Jo